دورية أكاديمية
The Effect of Apalutamide on Thyroid Function in Prostate Cancer Patients.
العنوان: | The Effect of Apalutamide on Thyroid Function in Prostate Cancer Patients. |
---|---|
المؤلفون: | Moffatt, Clare, Lechner, Melissa G, Angell, Trevor E, Shen, John, Drakaki, Alexandra, Acosta, Gonzalo J, Liang, Tom Z, Tsai, Karen |
المصدر: | J Endocr Soc ; ISSN:2472-1972 ; Volume:8 ; Issue:7 |
بيانات النشر: | PubMed Central |
سنة النشر: | 2024 |
المجموعة: | PubMed Central (PMC) |
مصطلحات موضوعية: | apalutamide, hypothyroidism, levothyroxine, thyroid dysfunction, thyroid function tests, thyroid hormone replacement |
الوصف: | Apalutamide (APT) is a nonsteroidal antiandrogen medication used to treat metastatic castrate-sensitive and nonmetastatic castrate-resistant prostate cancer. Early clinical trials of APT identified thyroid dysfunction as a common adverse effect of therapy, but the clinical presentation and management of APT-induced hypothyroidism has not been studied. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
العلاقة: | https://doi.org/10.1210/jendso/bvae105Test; https://pubmed.ncbi.nlm.nih.gov/38854906Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11156616Test/ |
DOI: | 10.1210/jendso/bvae105 |
الإتاحة: | https://doi.org/10.1210/jendso/bvae105Test https://pubmed.ncbi.nlm.nih.gov/38854906Test https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11156616Test/ |
حقوق: | © The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society. |
رقم الانضمام: | edsbas.B1122070 |
قاعدة البيانات: | BASE |
DOI: | 10.1210/jendso/bvae105 |
---|